# Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation

> **NCT04065633** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 46 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** P3-Fast
- **DRUG:** Comm-Fast
- **DRUG:** Vari-Fast
- **DRUG:** Comm-Fed

## Key facts

- **NCT ID:** NCT04065633
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2019-12-14
- **Final completion:** 2019-12-14
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065633, "Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04065633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*